BioSpace News Archive

Biotech Beach

Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting

Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”) today announced its participation in the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting, taking place in Orlando, Florida from April 14 through April 19, 2023, where VAL-083 data will be presented.

April 14, 2023

·

4 min read

Pharm Country

Flamingo Therapeutics Announces Poster Presentation on FTX-001 at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Flamingo Therapeutics (“Flamingo”) today announced a presentation at the 2023 American Association for Cancer Research (AACR) Annual Meeting, taking place April 14-19, 2023, in Orlando, Florida.

April 14, 2023

·

2 min read

Business

Rapid Dose Announces Board of Director Changes

Rapid Dose Therapeutics Corp., a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its board of directors.

April 14, 2023

·

4 min read

Business

Agena Bioscience and nRichDX Announce Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researchers developing liquid biopsy applications on the Agena MassARRAY platform.

April 14, 2023

·

3 min read

Policy

American Aires Inc. Announces Application to Extend Warrants

American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (the “Company” or “Aires”), a provider of scientifically-proven EMF modulation technology, announces that it intends to amend the expiry date of an aggregate

April 14, 2023

·

4 min read

Pharm Country

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia

CMML is an aggressive, poorly understood cancer; approximately 20% of patients survive three years from diagnosis

April 14, 2023

·

13 min read

Pharm Country

HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 14, 2023

HOOKIPA Pharma Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-statutory options to a new employee to purchase an aggregate of 50,000 shares of the Company’s Common Stock under HOOKIPA’s 2023 Inducement Plan.

April 14, 2023

·

1 min read

Genetown

Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Ocular Therapeutix, Inc. (NASDAQ:OCUL) announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held April 23 - 27 in New Orleans, Louisiana.

April 14, 2023

·

7 min read

InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares

InflaRx N.V. announced that it has completed its underwritten public offering of 9,411,765 ordinary shares at a public offering price of $4.25 per ordinary share.

April 14, 2023

·

6 min read

Drug Development

23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced results from the Phase 1 portion of its Phase 1/2a study evaluating 23ME-00610, an investigational antibody targeting CD200R1.

April 14, 2023

·

6 min read